Injection site rotation: difference between revisions
Diff·revision 11 → 12·17:24, 10 Apr 2025
Difference between revision 11 and revision 12 of Injection site rotation. 2 lines changed; the page grew by 167 bytes.
| Revision 11 — 00:02, 8 Mar 2025 CiteBot (talk) bot: add stub category 3,897 bytes ±0 | Revision 12 — 17:24, 10 Apr 2025 EscalationEira (talk) state that swirling rather than shaking is the handling convention, sourced 4,064 bytes +167 | ||
|---|---|---|---|
| 31 | For a preparation whose absorption is not rate-limiting — a weekly [[Albumin binding half-life extension|albumin-bound]] peptide, for example — the second pattern's variability is of little consequence, and the choice between the first two is not clinically significant on pharmacokinetic grounds.{{r|richter2012}} | 31 | For a preparation whose absorption is not rate-limiting — a weekly [[Albumin binding half-life extension|albumin-bound]] peptide, for example — the second pattern's variability is of little consequence, and the choice between the first two is not clinically significant on pharmacokinetic grounds.{{r|richter2012}} |
| 32 | 32 | ||
| + | 33 | This article describes practices reported in the clinical literature. It is not medical advice, and research-use compounds are not approved for human administration. | |
| + | 34 | ||
| 33 | == References == | 35 | == References == |
| 34 | {{reflist}} | 36 | {{reflist}} |